Robuta

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-00041
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
phesgomaintenancedxdshortinduction